The Charter of the French Language and its regulations govern the consultation of English-language content.


2601 Chemin de la Canardière
Québec (Québec)
G1J 2G3
Canada
Professeur associé retraité
Département de psychiatrie et de neurosciences, Faculté de Médecine
Axe de recherche:
Neurosciences cellulaires et moléculaires
Le Professeur Edouard Khandjian étudie les mécanismes moléculaires sous-tendant le syndrome de l’X fragile, qui est une maladie héréditaire qui cause un retard mental important – Il s’agit de la forme de retard mental héréditaire la plus commune, et une cause importante d’autisme qui se manifeste par des difficultés d’apprentissage, des troubles du langage et des comportements hyperactifs ou autistiques. Ce syndrome est causé par l’absence de la protéine FMRP (Fragile X Mental Retardation Protein), résultant de mutations dans le gène FMR1 situé sur le chromosome X.
Les travaux de l’équipe du Pr Khandjian ont montré que FMRP joue un rôle important dans le transport des ARN messagers entre le noyau de la cellule, où ils sont produits, et les sites distants, tels les synapses dans les neurones,où ils sont utilisés pour produire localement des protéines. Ces chercheurs ont montré que FMRP était présent dans des structures complexes microscopiques sous forme de granules mobiles formés d’ARN messager et de la machinerie moléculaire nécessaire pour produire des protéines lorsqu’ils sont rendus à leur destination. Cet important transport, qui peut s’effectuer sur des distances qui peuvent atteindre un mètre chez les humains, permet aux cellules de produire des protéines spécifiques aux endroits où elles sont requises.
La découverte du Pr Khandjian explique le rôle de FMRP dans la formation des granules, et confirme le rôle important de ceux-ci dans le transport à l’intérieur des cellules. En l’absence parfait de ce transport, le développement des neurones ne peut s’effectuer normalement, menant aux problèmes observés chez les personnes souffrant de la maladie de l’X fragile. Cette découverte pourrait aussi aider à comprendre d’autres maladies impliquant des protéines qui lient l’ARN, comme la sclérose latérale amyotrophique et l’atrophie musculaire spinale.
Le Retard Mental Héréditaire avec syndrome de l’X fragile (FXS) touche environ 1 personne sur 5000 de par le monde. Ce syndrome est causé par l’absence de la Fragile X Mental Retardation Protein (FMRP), une protéine de liaison à l’ARN. FMRP associée aux structures RiboNucleoProtéines porteuses des ARN messagers (mRNP) semble être impliquée dans différentes étapes de leurs transports et du contrôle de la traduction dans les neurones. Cependant, les mécanismes moléculaires par lesquels FMRP contrôle la régulation de l’ARNm demeurent inconnus. Nous étudions FMRP présente dans les structures RNP appelées «Granules» qui contiennent des ARNm réprimés pour être transportés loin du corps cellulaire vers les épines dendritiques. Ces ARNm sont traduits en protéines nécessaires pour répondre aux besoins locaux du neurone. La perte de FMRP induit la formation d’épines dendritiques immatures tant chez les patients X fragiles que chez la souris nulle et conduit à des altérations de la plasticité synaptique.
Lizenz Rer Nat. U-Fribourg, Suisse. 1972
Doctorat es Sciences Biologiques U-Genève, Suisse. 1977
Maitre-assistant, Dept Bilogie Moléculaire, Genève, Suisse. 1980-1984.
Chargé de recherche, Dept Biologie Moléculaire, Genève, Suisse. 1985-1988.
Directeur Banque Lymphoblastique RMGA-FRSQ. 1988-2008.
Directeur Unité Génétique humaine et moléculaire, HSFA, Québec. 1988-2008.
Professseur U.Laval.Québec. 1999-
Gabriel Sanchez; Alain Y Dury; Lyndsay M Murray; Olivier Biondi; Helina Tadesse; Rachid El Fatimy; Rashmi Kothary; Frédéric Charbonnier; Edouard W Khandjian; Jocelyn Côté
A novel function for the survival motoneuron protein as a translational regulator Article de journal
Dans: Hum Mol Genet, vol. 22, no 4, p. 668–684, 2013, ISSN: 1460-2083.
@article{pmid23136128,
title = {A novel function for the survival motoneuron protein as a translational regulator},
author = {Gabriel Sanchez and Alain Y Dury and Lyndsay M Murray and Olivier Biondi and Helina Tadesse and Rachid El Fatimy and Rashmi Kothary and Frédéric Charbonnier and Edouard W Khandjian and Jocelyn Côté},
doi = {10.1093/hmg/dds474},
issn = {1460-2083},
year = {2013},
date = {2013-02-01},
journal = {Hum Mol Genet},
volume = {22},
number = {4},
pages = {668--684},
abstract = {SMN1, the causative gene for spinal muscular atrophy (SMA), plays a housekeeping role in the biogenesis of small nuclear RNA ribonucleoproteins. SMN is also present in granular foci along axonal projections of motoneurons, which are the predominant cell type affected in the pathology. These so-called RNA granules mediate the transport of specific mRNAs along neurites and regulate mRNA localization, stability, as well as local translation. Recent work has provided evidence suggesting that SMN may participate in the assembly of RNA granules, but beyond that, the precise nature of its role within these structures remains unclear. Here, we demonstrate that SMN associates with polyribosomes and can repress translation in an in vitro translation system. We further identify the arginine methyltransferase CARM1 as an mRNA that is regulated at the translational level by SMN and find that CARM1 is abnormally up-regulated in spinal cord tissue from SMA mice and in severe type I SMA patient cells. We have previously characterized a novel regulatory pathway in motoneurons involving the SMN-interacting RNA-binding protein HuD and CARM1. Thus, our results suggest the existence of a potential negative feedback loop in this pathway. Importantly, an SMA-causing mutation in the Tudor domain of SMN completely abolished translational repression, a strong indication for the functional significance of this novel SMN activity in the pathology.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Marc-Etienne Huot; Nicolas Bisson; Thomas Moss; Edouard W Khandjian
Manipulating the fragile X mental retardation proteins in the frog Article de journal
Dans: Results Probl Cell Differ, vol. 54, p. 165–179, 2012, ISSN: 0080-1844.
@article{pmid22009352,
title = {Manipulating the fragile X mental retardation proteins in the frog},
author = {Marc-Etienne Huot and Nicolas Bisson and Thomas Moss and Edouard W Khandjian},
doi = {10.1007/978-3-642-21649-7_9},
issn = {0080-1844},
year = {2012},
date = {2012-01-01},
journal = {Results Probl Cell Differ},
volume = {54},
pages = {165--179},
abstract = {The frog is a model of choice to study gene function during early development, since a large number of eggs are easily obtained and rapidly develop external to the mother. This makes it a highly flexible model system in which direct tests of gene function can be investigated by microinjecting RNA antisense reagents. Two members of the Fragile X Related (FXR) gene family, namely xFmr1 and xFxr1 have been identified in Xenopus. While the tissue distribution of their products was found to be identical to that in mammals, the pattern of isoform expression is less complex. Translational silencing of the xFmr1 and xFxr1 mRNAs by microinjection of antisense morpholino oligonucleotides (MO) induced dramatic morphological alterations, revealing tissue-specific requirements for each protein during development and in maintaining the steady state levels of a range of transcripts in these tissues. The power and versatility of the frog model is that the MO-induced phenotypes can be rescued by microinjection of the corresponding MO-insensitive mRNAs. Most importantly, this animal model allows one rapidly to determine whether any member of the FXR family can compensate for the absence of another, an approach that cannot be performed in other animal models.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Rachid El Fatimy; Sandra Tremblay; Alain Y Dury; Samuel Solomon; Paul De Koninck; John W Schrader; Edouard W Khandjian
Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected] Article de journal
Dans: PLoS One, vol. 7, no 6, p. e39338, 2012, ISSN: 1932-6203.
@article{pmid22737234,
title = {Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected]},
author = {Rachid El Fatimy and Sandra Tremblay and Alain Y Dury and Samuel Solomon and Paul De Koninck and John W Schrader and Edouard W Khandjian},
doi = {10.1371/journal.pone.0039338},
issn = {1932-6203},
year = {2012},
date = {2012-01-01},
journal = {PLoS One},
volume = {7},
number = {6},
pages = {e39338},
abstract = {Fragile X syndrome is caused by the absence of the Fragile X Mental Retardation Protein (FMRP), an RNA-binding protein. FMRP is associated with messenger RiboNucleoParticles (mRNPs) present in polyribosomes and its absence in neurons leads to alteration in synaptic plasticity as a result of translation regulation defects. The molecular mechanisms by which FMRP plays a role in translation regulation remain elusive. Using immunoprecipitation approaches with monoclonal Ab7G1-1 and a new generation of chicken antibodies, we identified Caprin1 as a novel FMRP-cellular partner. In vivo and in vitro evidence show that Caprin1 interacts with FMRP at the level of the translation machinery as well as in trafficking neuronal granules. As an RNA-binding protein, Caprin1 has in common with FMRP at least two RNA targets that have been identified as CaMKIIα and Map1b mRNAs. In view of the new concept that FMRP species bind to RNA regardless of known structural motifs, we propose that protein interactors might modulate FMRP functions.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Denise Cook; Maria del Rayo Sanchez-Carbente; Claude Lachance; Danuta Radzioch; Sandra Tremblay; Edouard W Khandjian; Luc DesGroseillers; Keith K Murai
Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus Article de journal
Dans: PLoS One, vol. 6, no 10, p. e26120, 2011, ISSN: 1932-6203.
@article{pmid22022532,
title = {Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus},
author = {Denise Cook and Maria del Rayo Sanchez-Carbente and Claude Lachance and Danuta Radzioch and Sandra Tremblay and Edouard W Khandjian and Luc DesGroseillers and Keith K Murai},
doi = {10.1371/journal.pone.0026120},
issn = {1932-6203},
year = {2011},
date = {2011-01-01},
journal = {PLoS One},
volume = {6},
number = {10},
pages = {e26120},
abstract = {The formation and storage of memories in neuronal networks relies on new protein synthesis, which can occur locally at synapses using translational machinery present in dendrites and at spines. These new proteins support long-lasting changes in synapse strength and size in response to high levels of synaptic activity. To ensure that proteins are made at the appropriate time and location to enable these synaptic changes, messenger RNA (mRNA) translation is tightly controlled by dendritic RNA-binding proteins. Fragile X Related Protein 1 (FXR1P) is an RNA-binding protein with high homology to Fragile X Mental Retardation Protein (FMRP) and is known to repress and activate mRNA translation in non-neuronal cells. However, unlike FMRP, very little is known about the role of FXR1P in the central nervous system. To understand if FXR1P is positioned to regulate local mRNA translation in dendrites and at synapses, we investigated the expression and targeting of FXR1P in developing hippocampal neurons in vivo and in vitro. We found that FXR1P was highly expressed during hippocampal development and co-localized with ribosomes and mRNAs in the dendrite and at a subset of spines in mouse hippocampal neurons. Our data indicate that FXR1P is properly positioned to control local protein synthesis in the dendrite and at synapses in the central nervous system.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Anna Iacoangeli; Timofey S Rozhdestvensky; Natalia Dolzhanskaya; Barthélémy Tournier; Janin Schütt; Jürgen Brosius; Robert B Denman; Edouard W Khandjian; Stefan Kindler; Henri Tiedge
On BC1 RNA and the fragile X mental retardation protein Article de journal
Dans: Proc Natl Acad Sci U S A, vol. 105, no 2, p. 734–739, 2008, ISSN: 1091-6490.
@article{pmid18184799,
title = {On BC1 RNA and the fragile X mental retardation protein},
author = {Anna Iacoangeli and Timofey S Rozhdestvensky and Natalia Dolzhanskaya and Barthélémy Tournier and Janin Schütt and Jürgen Brosius and Robert B Denman and Edouard W Khandjian and Stefan Kindler and Henri Tiedge},
doi = {10.1073/pnas.0710991105},
issn = {1091-6490},
year = {2008},
date = {2008-01-01},
journal = {Proc Natl Acad Sci U S A},
volume = {105},
number = {2},
pages = {734--739},
abstract = {The fragile X mental retardation protein (FMRP), the functional absence of which causes fragile X syndrome, is an RNA-binding protein that has been implicated in the regulation of local protein synthesis at the synapse. The mechanism of FMRP's interaction with its target mRNAs, however, has remained controversial. In one model, it has been proposed that BC1 RNA, a small non-protein-coding RNA that localizes to synaptodendritic domains, operates as a requisite adaptor by specifically binding to both FMRP and, via direct base-pairing, to FMRP target mRNAs. Other models posit that FMRP interacts with its target mRNAs directly, i.e., in a BC1-independent manner. Here five laboratories independently set out to test the BC1-FMRP model. We report that specific BC1-FMRP interactions could be documented neither in vitro nor in vivo. Interactions between BC1 RNA and FMRP target mRNAs were determined to be of a nonspecific nature. Significantly, the association of FMRP with bona fide target mRNAs was independent of the presence of BC1 RNA in vivo. The combined experimental evidence is discordant with a proposed scenario in which BC1 RNA acts as a bridge between FMRP and its target mRNAs and rather supports a model in which BC1 RNA and FMRP are translational repressors that operate independently.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
2004, ISSN: 1468-6244.
@misc{pmid15060119,
title = {Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome},
author = {F Tassone and R J Hagerman and D Garcia-Arocena and E W Khandjian and C M Greco and P J Hagerman},
doi = {10.1136/jmg.2003.012518},
issn = {1468-6244},
year = {2004},
date = {2004-04-01},
journal = {J Med Genet},
volume = {41},
number = {4},
pages = {e43},
keywords = {},
pubstate = {published},
tppubtype = {misc}
}
Aida Bairam; John L Carroll; Yves Labelle; Edouard W Khandjian
Differential changes in dopamine D2- and D1-receptor mRNA levels induced by hypoxia in the arterial chemoreflex pathway organs in one-day-old and adult rabbits Article de journal
Dans: Biol Neonate, vol. 84, no 3, p. 222–231, 2003, ISSN: 0006-3126.
@article{pmid14504446,
title = {Differential changes in dopamine D2- and D1-receptor mRNA levels induced by hypoxia in the arterial chemoreflex pathway organs in one-day-old and adult rabbits},
author = {Aida Bairam and John L Carroll and Yves Labelle and Edouard W Khandjian},
doi = {10.1159/000072306},
issn = {0006-3126},
year = {2003},
date = {2003-01-01},
journal = {Biol Neonate},
volume = {84},
number = {3},
pages = {222--231},
abstract = {This study determined: (1) whether dopamine (DA) D2-receptor (R) and D1-R mRNA levels in the carotid body (CB), petrosal ganglion (PG) and superior cervical ganglion (SCG) are modulated by hypoxia; (2) the role of hypoxia intensity and exposure duration, and (3) whether the pattern of modulation differs between newborn (1-day-old) and adult rabbits. Rabbits were exposed to five FiO2 conditions: 21% (control); 15%/6 h; 15%/24 h; 8%/6 h and 8%/24 h. D2- and D1-R mRNA expression levels were calculated for each hypoxia condition relative to control using RT-PCR analysis. In the CB of 1-day-old rabbits, D2- and D1-R transcript levels increased and decreased after exposure to 15 and 8% O2, respectively. In the adult CB, D2- and D1-R transcript levels decreased independently of hypoxia intensities. Only changes in D1-R mRNA levels were dependent on exposure time. In the PG, both hypoxia intensities decreased the D2-R transcript levels in 1-day-old and adult rabbits; but for the D1-R mRNA levels, hypoxia decreased its level in 1-day-old rabbits and increased it in adults regardless of exposure duration. In the SCG, hypoxia had no determinant effect on the D2-R mRNA levels either in newborn or adult rabbits while it induced a decrease of D1-R transcript levels in 1-day-old rabbits and an increase in adult rabbits. It is concluded that hypoxia affects DA D2- or D1-R mRNA levels in the chemoreflex pathway in an age-dependent and site-specific manner.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}